State Of New Jersey Common Pension Fund D Editas Medicine, Inc. Transaction History

State Of New Jersey Common Pension Fund D

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$14.08 - $27.63 $1.12 Million - $2.2 Million	-79,452 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$26.55 - $40.57 $906,310 - $1.38 Million	34,136 Added 75.33%	79,452 $2.11 Million
Q3 2021 Oct 27, 2021	SELL	$39.27 - $72.94 $1.13 Million - $2.1 Million	-28,748 Reduced 38.82%	45,316 $1.86 Million
Q2 2021 Jul 23, 2021	BUY	$31.29 - $56.64 $1.05 Million - $1.89 Million	33,409 Added 82.18%	74,064 $4.2 Million
Q1 2021 Apr 27, 2021	SELL	$39.71 - $90.58 $923,853 - $2.11 Million	-23,265 Reduced 36.4%	40,655 $1.71 Million
Q4 2020 Feb 03, 2021	SELL	$27.07 - $84.35 $43,149 - $134,453	-1,594 Reduced 2.43%	63,920 $4.48 Million
Q3 2020 Oct 27, 2020	SELL	$28.06 - $37.16 $218,643 - $289,550	-7,792 Reduced 10.63%	65,514 $1.84 Million
Q2 2020 Aug 04, 2020	BUY	$18.5 - $34.34 $1.36 Million - $2.52 Million	73,306 New	73,306 $2.17 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.